Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
UFP Technologies
UFPT
UFP Technologies
Aging Global Population And Nearshoring Will Fuel MedTech Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
11 May 25
Updated
08 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$370.00
39.5% undervalued
intrinsic discount
08 Aug
US$224.00
Loading
1Y
-30.4%
7D
8.6%
Author's Valuation
US$370.0
39.5% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$370.0
39.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
778m
2014
2017
2020
2023
2025
2026
2028
Revenue US$778.3m
Earnings US$109.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.60%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.71%
Calculation
US$109.67m
Earnings '28
x
32.92x
PE Ratio '28
=
US$3.61b
Market Cap '28
US$3.61b
Market Cap '28
/
7.81m
No. shares '28
=
US$461.97
Share Price '28
US$461.97
Share Price '28
Discounted to 2025 @ 7.68% p.a.
=
US$369.97
Fair Value '25